Pharmaceutical IT Spending Forecast in the US to

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

  • $ 645
  • Industry report
  • by Firstword Pharma
  • Nov 2014

The potential blockbuster status of Novartis' LCZ696 has seemingly been cemented in the eyes of the Street thanks to solid results from the Phase III PARADIGM-HF study that were presented over the weekend. Indeed, the chronic heart failure agent is believed to represent both a significant growth drive ...

Industries: Pathology | Countries: United States

Cairo Pharmaceuticals & Chem. Industries

Cairo Pharmaceuticals & Chem. Industries

  • $ 55
  • Company report
  • by Wright Investors' Service
  • November 2014
  • 55 pages

A textual analysis of the financial results for Cairo Pharmaceuticals & Chem. Industries compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Pharmaceutical | Countries: United States

Anthera Pharmaceuticals‚ Inc. (Symbol:ANTH) SWOT Analysis, Strategy, Revenues and Profits

Anthera Pharmaceuticals‚ Inc. (Symbol:ANTH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Anthera Pharmaceuticals‚ Inc. SWOT Analysis report provides you ...

Industries: Pathology | Countries: United States

BB BIOTECH AG (Symbol:BION) SWOT Analysis, Strategy, Revenues and Profits

BB BIOTECH AG (Symbol:BION) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. BB BIOTECH AG SWOT Analysis report provides you a strategic analysis ...

Industries: Pathology | Countries: United States, Switzerland

BioRx, LLC SWOT Analysis, Strategy, Revenues and Profits

BioRx, LLC SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Pathology | Countries: United States

Caraco Pharmaceutical Laboratories, Ltd. (Symbol:CPD) SWOT Analysis, Strategy, Revenues and Profits

Caraco Pharmaceutical Laboratories, Ltd. (Symbol:CPD) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Caraco Pharmaceutical Laboratories, Ltd. SWOT Analysis report provides ...

Industries: Pharmaceutical | Countries: United States

Genoptix, Inc. (Symbol:GXDX) SWOT Analysis, Strategy, Revenues and Profits

Genoptix, Inc. (Symbol:GXDX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Genoptix, Inc. SWOT Analysis report provides you a strategic analysis ...

Industries: Pathology | Countries: United States

Prana Biotechnology Limited (Symbol:PBT) SWOT Analysis, Strategy, Revenues and Profits

Prana Biotechnology Limited (Symbol:PBT) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Prana Biotechnology Limited SWOT Analysis report provides you a strategic ...

Industries: Pathology | Countries: United States

Daiichi Sankyo, Inc. SWOT Analysis, Strategy, Revenues and Profits

Daiichi Sankyo, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Pathology | Countries: United States

Deltagen, Inc. (Symbol:DGEN) SWOT Analysis, Strategy, Revenues and Profits

Deltagen, Inc. (Symbol:DGEN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Deltagen, Inc. SWOT Analysis report provides you a strategic analysis ...

Industries: Drug Discovery and Development | Countries: United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 339 368 6001

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.